Skip to main content

Table 2 Medications received during the one-year pre-index period (indexdate-365 days to indexdate-1 day)

From: Treatment patterns of patients diagnosed with major depressive disorder and suicidal ideation or attempt: a U.S. population-based study utilizing real-world data

Medication

%

Treatment classes of interest

 SSRI

43.1%

 Anxiolytic

34.7%

 Anticonvulsant

27.9%

 Other antidepressants

25.6%

 Hypnotics and Sedatives

16.9%

 SNRI

16.5%

 Psychostimulant

7.2%

 Tricyclic

5.5%

 Atypical antipsychotic

5.3%

 Lithium

0.4%

 MAOI

0.1%

  1. SSRI selective serotonin reuptake inhibitor, SNRI serotonin and norepinephrine reuptake inhibitor, MAOI monoamine oxidase inhibitor.